UPDATED May 31, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RWAY | €5.23 | 3.6% | -1.3% | €1.4b | €6.98 | PE16.1x | E0.7% | 6.2% | Telecom | ||
CHEMM | kr.363.20 | -0.9% | -27.2% | kr.6.3b | kr.437.50 | PE44x | E11.6% | 1.7% | Pharmaceuticals & Biotech | ||
TCBX | US$21.09 | -1.4% | 24.1% | US$283.6m | US$24.75 | PB0.7x | E15.6% | n/a | Banks | ||
FRU | €5.98 | 6.8% | 56.5% | €129.3m | €8.97 | PE11.2x | E18.5% | 3.2% | Diversified Financials | ||
MULTI | kr149.50 | -2.9% | -6.3% | kr4.1b | kr160.00 | PE16.1x | E10.8% | 5.4% | Commercial Services | ||
OHLA | €0.42 | 0.4% | -12.2% | €248.9m | n/a | PE38.3x | E46.5% | 0% | Capital Goods | ||
BCML | US$20.18 | -0.9% | 19.1% | US$224.9m | US$23.67 | PB0.7x | E-7.5% | 2.0% | Banks | ||
BXPHARMA | ৳109.10 | -0.2% | -25.4% | ৳48.7b | ৳177.50 | PE9.1x | E15.6% | 3.2% | Pharmaceuticals & Biotech | ||
OLYMPIC | ৳131.80 | 1.9% | -14.9% | ৳26.4b | ৳173.57 | PE15.8x | E13.9% | 4.6% | Food, Beverage & Tobacco | ||
MDNE3 | R$11.00 | -6.2% | 36.6% | R$921.3m | R$16.00 | PE5.5x | E26.0% | n/a | Real Estate Management and Development | ||
VFQS | ر.ق1.68 | 1.4% | -8.5% | ر.ق7.1b | ر.ق2.15 | PE12.7x | E7.5% | 6.6% | Telecom | ||
GDG | AU$2.25 | -0.4% | 73.7% | AU$429.1m | AU$2.54 | PE54.3x | E32.9% | 0.9% | Insurance |